Nasdaq Stockholm

Cinclus Pharma Holding AB (publ)

ISIN SE0020388577Filings at the FI

At a glance

Most recent filing on June 8, 2026 — an open-market purchase by Gösta Hiller on Jun 8, 2026.

We hold 30 visible filings, going back to June 19, 2024.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

5 of 30 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 30. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Gösta Hiller Other senior executive
12,380 SEKOpen-market buy
TradedJun 8, 2026FiledJun 8, 2026
Gösta Hiller Other senior executive
24,280 SEKOpen-market buy
TradedJun 5, 2026FiledJun 5, 2026
Kajsa Anna Margareta Larsson Other member of the administrative, management or supervisory body
157,300 SEKOpen-market buy
TradedJun 4, 2026FiledJun 5, 2026
Magnus Christensen Chief financial officer
85,260 SEKOpen-market buy
TradedMay 15, 2026FiledMay 18, 2026
Magnus Christensen Chief financial officer
104,650 SEKOpen-market buy
TradedApr 7, 2026FiledApr 9, 2026